149
Views
1
CrossRef citations to date
0
Altmetric
Brief Report

Efficacy and safety of the switch of Triumeq® to generic (abacavir + lamivudine) + Tivicay®: data at 48 weeks

, , , , , , , , & show all
Pages 691-693 | Received 17 Jun 2019, Accepted 24 Jun 2019, Published online: 05 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ignacio Pérez-Valero, Diana Corona, Natalia Martínez, María López-Cavanillas, Carla Lluis & Isabel Luque. (2023) Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review. Expert Review of Anti-infective Therapy 21:6, pages 655-665.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.